本頁面由Tiger Trade Technology Pte. Ltd.提供服務

eFFECTOR Therapeutics, Inc.

0.0002
0.0000
成交量:404.00
成交額:0.08
市值:940.88
市盈率:0.00
高:0.0002
開:0.0002
低:0.0002
收:0.0002
52周最高:0.0200
52周最低:0.0000
股本:470.44萬
流通股本:458.21萬
量比:1.21
換手率:0.01%
股息:- -
股息率:- -
每股收益(TTM):-12.4244
每股收益(LYR):-16.3748
淨資產收益率:-946.56%
總資產收益率:-83.33%
市淨率:0.00
市盈率(LYR):0.00

資料載入中...

2022/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/31

SEC問詢函

CORRESP [Cover] - Correspondence
2022/01/31

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/25

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/01/24

重要事件披露

8-K - Current report
2021/11/08

重要事件披露

8-K - Current report
2021/11/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/11/01

重要事件披露

8-K - Current report
2021/10/01

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/01

SEC問詢函

CORRESP [Cover] - Correspondence
2021/09/23

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/09/13

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/07

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/03

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/31

重要事件披露

8-K - Current report
2021/08/31

重要事件披露

8-K/A [Amend] - Current report
2021/08/25

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/25

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/08/24

重要事件披露

8-K - Current report